Navigation Links
ASPIRE Phase III trial of vaginal ring to prevent HIV completes enrollment of 2,629 women
Date:6/26/2014

the timeline to the ring's potential approval.

Vaginal rings are flexible products that fit comfortably high up inside the vagina and provide sustained delivery of active agents over a period of time. Vaginal rings are already used in many countries to deliver hormonal contraception. The dapivirine ring adapts that medical technology as a way to offer women potentially long-acting protection against HIV. It is the first long-acting ARV-based product to enter efficacy testing and the first involving an ARV other than tenofovir or a tenofovir combination. Moreover, unlike tenofovir, dapivirine is not a drug used in the treatment of HIV.

"Perhaps the most attractive aspect about a vaginal ring as an HIV prevention method is that women can use it discreetly and use it up to a month at a time due to the slow release of the medication it contains. If the women in our trial find it easy and practical to use consistently, this will be extremely important, because only if it is used as directed are we able to assess its true effectiveness," said Thesla Palanee, Ph.D., ASPIRE protocol co-chair who also directs the study at her own institution, the Wits Reproductive Health and HIV Institute (Wits RHI) in Johannesburg, South Africa..

ASPIRE is completing enrollment with fewer participants than originally planned. The research team had assumed needing to enroll up to 3,476 women to answer the study's primary questions about safety and effectiveness, a calculation based in part on a background HIV incidence rate of 3.9 percent in trial site communities at the time the protocol was being developed. In March 2013, however, when ASPIRE was already seven months into the study, results were reported of another HIV prevention trial called VOICE indicating the HIV incidence in a very similar population was much higher, at 5.7 percent. Adjusting for both the higher HIV incidence as well as the fact that the study has more women than expected using the ring wel
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-641-8940
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. MyPuress Announces Expansion into Canadian Market with Release of Aspiree Product Line
2. ALS patients differ on treatment choices in later phases of disease
3. Reach2HD, a Phase II study in Huntingtons disease, launched
4. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
5. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
6. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
7. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
8. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
9. Positive results from Phase 1/2 stem cell trial reported
10. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
11. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... (PRWEB) August 22, 2014 Buying a policy ... adult who is unsure about available coverage types by insurers ... principal life insurance policy pricing to the public using its ... of this tool is free and is expected to promote ... to the public throughout the U.S. The system is designed ...
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 Millennium Treatment ... marijuana, resulting in a high level of drug use among ... ages fight against drug addiction and work to minimize drug ... levels of alcohol and drug addiction in history. According to ... an estimated 23.9 million Americans aged 12 or older—or 9.2 ...
(Date:8/22/2014)... HealthDay Reporter FRIDAY, Aug. 22, ... on work disability chronically use powerful prescription painkillers, according ... 2007 and 2011, about 44 percent of people receiving ... each year. And the percentage using the drugs long-term ... in 2011. Experts said the trend is ...
(Date:8/22/2014)... know little about how Ebola is transmitted and harbor unfounded ... States, a new survey shows. About four in 10 ... major Ebola outbreak in the United States, and one-quarter are ... sick with the deadly virus in the next year, according ... However, those opinions don,t match reality, the Harvard researchers noted. ...
(Date:8/22/2014)... 2014 Natural Clear Vision , a ... his own vision from legally blind to perfect 20/20 vision ... review. , “There is a huge portion of the ... function, and most people just think that’s the way it ... that can be pretty risky at times,” reports Michaels. “This ...
Breaking Medicine News(10 mins):Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2
... RENO, Nev., Nov. 20 Employers Occupational,Health, ... (NYSE: EIG ), announced,today that it ... URAC, a,Washington, D.C.-based health care accrediting organization ... industry. URAC,s Case,Management Accreditation standards require companies ...
... known for years that psychological trauma that results ... change how a person responds to stress. Now, ... loved ones, life-threatening accidents and other such traumas ... survivor doesn,t develop a clinical disorder., "The findings ...
... assumed to be the top truants in American medicine, not ... less treatable. However, a new study by Dartmouth researchers suggests ... through the cracksat least when it comes to colorectal and ... types of cancer, the study found that urban patients tend ...
... Corporation,(Nasdaq: RGEN ) announced today that the Company President ... two upcoming,healthcare conferences in New York, NY. -- Lazard ... Wednesday, November 28, 2007 at 11:00 A.M. EST at ... Madison Avenue, New York, NY. -- BMO Capital Markets ...
... in Molecular Imaging Zone, FORT LAUDERDALE, Fla., ... Board: IMDS) a pioneer in laser,optical breast cancer ... cancer cases imaged with optical computed tomography,technologies at ... - 28. A CT,Laser Mammography (CTLM(R)) system and ...
... 21st, Prey Veng Province, PHNOM PENH, Cambodia, ... AIDS organization in the United,States, which operates free ... and Asia, is honored to announce the opening ... The facility, AHF,s seventh,in the country, opens Wednesday, ...
Cached Medicine News:Health News:Employers Occupational Health, Inc. Receives URAC Case Management Accreditation 2Health News:Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 3Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 2Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 3Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 2Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 3Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 4
(Date:8/22/2014)... Research and Markets  has announced the ... Tools & Technologies" report to their offering. ... products or you wish to expand your product line, ... is. The authors know you want to make effective ... to generate improved revenues and take market share from ...
(Date:8/22/2014)...   Zacks Equity Research highlights Epizyme (Nasdaq: EPZM ... Panera (Nasdaq: PNRA - Free Report ) as the Bear ... Amicus Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... - Free Report ). Here is a synopsis of ... : The biotech bull market is far from ...
(Date:8/22/2014)... August 22, 2014 ... Today Lincor announced general availability of ... that delivers a range of education, entertainment and clinical ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , " ... of care patient engagement to bedside smart devices, " ...
Breaking Medicine Technology:Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Lincor Unveils Next Generation TV-based Patient Engagement Solution 2
... Biopharmaceuticals Plc, a,biopharmaceutical company focused on the development ... initiated a Phase II,equivalent study of MRX-4, in ... allergic rhinitis (AR). The two-arm, randomized, multi-dose,double-blind, placebo-controlled ... study is expected to be completed by the ...
... Society, American Society of Breast Surgeons and American College ... ... Oncology, SUNNYVALE, Calif., June 24 Xoft, Inc. today announced,the ... national Electronic Brachytherapy patient registry,under oversight from three national physician societies, ...
Cached Medicine Technology:Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 3First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 4
10 plate suitable for children and the illiterate....
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Berke ptosis clamp...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Medicine Products: